NF-κB inhibitor containing substituted benzoic acid...

Details NF-κB inhibitor containing substituted benzoic acid... NF-κB inhibitor containing substituted benzoic acid...

2006-06-20

2006-06-20

Tsang, Cecilia J. (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S256000, C514S317000, C514S318000, C514S319000, C514S326000, C514S330000, C514S336000, C514S354000, C514S355000, C514S396000, C514S397000, C514S399000, C514S532000, C514S568000, C514S688000, C514S689000, C544S111000, C544S124000, C544S125000, C544S128000, C544S129000, C546S192000, C546S193000, C546S194000, C546S208000, C546S218000, C546S221000, C546S268100, C546S276400, C546S281700, C546S289000, C546S314000, C552S293000, C552S307000, C552S309000, C552S310000, C560S008000, C560S055000, C560S057000

Reexamination Certificate

active

07064124

ABSTRACT:
A NF-κB inhibitor represented by the following formula (I) is provided: 

REFERENCES:
patent: 62286949 (1987-12-01), None
patent: 04226937 (1992-08-01), None
patent: 07291859 (1995-11-01), None
patent: 0955372 (1999-11-01), None
patent: 99/48491 (1999-09-01), None
Lewis Mander et al, “Studies on Reductive Alkylation. Regiocontrolled Synthesis of Anthracene Derivatives,” Aust. J. Chem., 34, 1981, pp. 2249-2252.

Affiliated with

Also associated with

Rating

NF-κB inhibitor containing substituted benzoic acid... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with NF-κB inhibitor containing substituted benzoic acid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and NF-κB inhibitor containing substituted benzoic acid... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3619215